We are IntechOpen, the world's leading publisher of Open Access books Built by scientists, for scientists

6,300+

Open access books available

170,000+

190M+

International authors and editors

Downloads

156 Countries delivered to Our authors are among the

Top 1% most cited scientists

Contributors from top 500 universities

Selection of our books indexed in the Book Citation Index in Web of Science™ Core Collection (BKCI)

### Interested in publishing with us? Contact book.department@intechopen.com

Numbers displayed above are based on latest data collected. For more information visit www.intechopen.com

## Meet the editor

Dr. Khalid Ahmed Al-Anazi is a consultant hemato-oncologist and was chairman of the Department of Adult Hematology and Hematopoietic Stem Cell Transplantation (HSCT), King Fahad Specialist Hospital (KFSH), Saudi Arabia, from 2015 to 2021. He trained in clinical hematology and HSCT at King's College Hospital, University of London, UK. He has 30 years of experience in adult clinical hematology and HSCT at Riyadh Armed

Forces Hospital; King Faisal Specialist Hospital and Research Centre (KFSH & RC); King Khalid University Hospital (KKUH) and the College of Medicine, King Saud University; and KFSH, Saudi Arabia. He established the adult HSCT program at KFSH in 2010. He received the best teacher award from the College of Medicine and KKUH in 2014. He has more than 140 publications to his credit, including retrospective studies, review articles, book chapters, and electronic books. He is a reviewer for twenty-four international medical journals and an associate editor for twenty-six others. He is the editor-in-chief of four journals in cell biology, regenerative medicine, and stem cell therapy.

### Contents



Preface

Over the past two decades, the outcome of multiple myeloma patients has substantially improved due to the introduction of several lines of novel therapies, the adoption of new therapeutic strategies, an increased understanding of disease biology, and recent

This book is a recent update on multiple myeloma. It is divided into three sections that cover a wide variety of topics, including diagnosis, risk stratification, and management of multiple myeloma; treatment of myeloma at diagnosis and at relapse;

I would like to thank the authors for their valuable contributions, as well as Publishing Manager Paula Gavran and the staff at IntechOpen for their remarkable efforts

**Khalid Ahmed Al-Anazi**

King Fahad Specialist Hospital, Dammam, Saudi Arabia

Department of Adult Hematology and Hematopoietic

Stem Cell Transplantation, Oncology Center,

management of renal failure in patients with multiple myeloma; and stem cell therapies in multiple myeloma. Each chapter is written by clinicians and scientists

advances in diagnostics and supportive care.

with expertise in the field.

throughout the publication process.
